Oxford Biomedica (LON:OXB) Shares Pass Above Two Hundred Day Moving Average – Should You Sell?

Oxford Biomedica plc (LON:OXB)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 600.87 and traded as high as GBX 850. Oxford Biomedica shares last traded at GBX 831, with a volume of 471,700 shares trading hands.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on OXB. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Oxford Biomedica from GBX 735 to GBX 800 and gave the company a “buy” rating in a research note on Friday, January 9th. Canaccord Genuity Group restated a “buy” rating and issued a GBX 451 target price on shares of Oxford Biomedica in a report on Tuesday, October 7th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Oxford Biomedica has a consensus rating of “Moderate Buy” and a consensus target price of GBX 606.40.

Oxford Biomedica Stock Down 2.2%

The stock has a 50 day moving average price of GBX 694.93 and a 200 day moving average price of GBX 602.53. The company has a debt-to-equity ratio of 166.48, a quick ratio of 1.67 and a current ratio of 2.35. The company has a market capitalization of £1.00 billion, a P/E ratio of -22.94 and a beta of 1.09.

Oxford Biomedica Company Profile

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.